Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucosal pentraxin 1 (MPTX1) is a short pentraxin protein highly homologous to other pentraxins such as serum amyloid P (SAP) and C-reactive protein (CRP). It is predominantly expressed in the colon mucosa of rats and mice, where its mRNA and protein levels fluctuate with dietary intake of heme and calcium. These properties suggest a role for MPTX1 as a nutrient-sensitive marker of mucosal health in rodents. However, in humans, MPTX1 is not functionally expressed due to a premature stop codon, and its physiological role is unknown. It is not considered a validated protein target in pharmacology or human biology, and should not be confused with neuronal pentraxin 1 (NPTX1), which is a different member of the pentraxin family with known functions in the nervous system[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucosal pentraxin 1 (MPTX1).